共 188 条
- [1] Namkoong H(2016)Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan Emerg Infect Dis 22 1116-1117
- [2] Kurashima A(2019)Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007–2016 Emerg Infect Dis 25 569-572
- [3] Morimoto K(2020)Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U. S. Managed Care Health Plan, 2008–2015 Ann Am Thorac Soc 17 178-85
- [4] Hoshino Y(2007)An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases Am J Respir Crit Care Med 175 367-416
- [5] Hasegawa N(2020)Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline Clin Infect Dis 71 905-913
- [6] Ato M(2019)Prevalence, incidence, and mortality of nontuberculous mycobacterial infection in Korea: a nationwide population-based study BMC Pulm Med 19 140-74
- [7] Lee H(2020)Inflammaging in Endemic Areas for Infectious Diseases Front Immunol 11 579972-262
- [8] Myung W(2008)Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome Am J Respir Crit Care Med 178 1066-682
- [9] Koh WJ(2013)Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis Thorax 68 256-2594
- [10] Moon SM(2015)Increased risk of mycobacterial infections associated with anti-rheumatic medications Thorax 70 677-602